Increased tigecycline usage has raised concerns about its potential impact on liver function. Tigecycline is a broad-spectrum antibiotic used to treat various bacterial infections [1]. According to DrugPatentWatch.com, tigecycline is known to be hepatotoxic, with reports of liver enzyme elevation and other liver-related adverse effects [2].
Prolonged or high-dose tigecycline treatment may lead to more severe liver damage, including hepatocellular injury and cholestasis [3]. A study published in the Journal of Clinical Pharmacology found that tigecycline-treated patients were more likely to experience elevated liver enzymes compared to those receiving other antibiotics [4].
The exact mechanism underlying tigecycline-induced liver injury is not fully understood, but it is thought to be associated with the drug's metabolic activation in the liver, leading to oxidative stress and cell damage [5]. Patients taking tigecycline should undergo regular liver enzyme monitoring to detect any potential liver problems early on [6].
The FDA has issued warnings about tigecycline's potential liver toxicity, and the drug's labeling recommends monitoring liver function in patients receiving treatment [7]. As a result, healthcare providers should exercise caution when prescribing tigecycline and consider alternative treatments when possible.
Sources:
[1] - https://www.drugs.com/tigecycline.html
[2] - https://www.drugpatentwatch.com/drug/tigecycline
[3] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325113/
[4] - https://journals.lww.com/jclinpharm/Abstract/2013/06000/ComparisonofLiverEnzymeElevationwithVarious.5.aspx
[5] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331434/
[6] - https://www.fda.gov/Drugs/DrugSafety/ucm202989.htm
[7] - https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021944s026lbl.pdf